Konjeti R Sekhar1, Mouadh Benamar2, Amudhan Venkateswaran1, Soumya Sasi1, Narsimha R Penthala3, Peter A Crooks3, Stephen R Hann4, Ling Geng1, Ramesh Balusu5, Tarek Abbas2, Michael L Freeman6. 1. Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. 2. Department of Radiation Oncology, University of Virginia School of Medicine, Charlottesville, Virginia. 3. Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, Arkansas. 4. Department of Cell and Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee. 5. Department of Internal Medicine, University of Kansas Medical Center, Kansas City, Kansas. 6. Department of Radiation Oncology, Vanderbilt University School of Medicine, Nashville, Tennessee. Electronic address: michael.freeman@vanderbilt.edu.
Abstract
PURPOSE: To test the hypothesis that small molecule targeting of nucleophosmin 1 (NPM1) represents a rational approach for radiosensitization. METHODS AND MATERIALS: Wilde-type and NPM1-deficient mouse embryo fibroblasts (MEFs) were used to determine whether radiosensitization produced by the small molecule YTR107 was NPM1 dependent. The stress response to ionizing radiation was assessed by quantifying pNPM1, γH2AX, and Rad51 foci, neutral comet tail moment, and colony formation. NPM1 levels in a human-derived non-small-cell lung cancer (NSCLC) tissue microarray (TMA) were determined by immunohistochemistry. YTR107-mediated radiosensitization was assessed in NSCLC cell lines and xenografts. RESULTS: Use of NPM1-null MEFs demonstrated that NPM1 is critical for DNA double- strand break (DSB) repair, that loss of NPM1 increases radiation sensitivity, and that YTR107-mediated radiosensitization is NPM1 dependent. YTR107 was shown to inhibit NPM1 oligomerization and impair formation of pNPM1 irradiation-induced foci that colocalized with γH2AX foci. Analysis of the TMA demonstrated that NPM1 is overexpressed in subsets of NSCLC. YTR107 inhibited DNA DSB repair and radiosensitized NSCLC lines and xenografts. CONCLUSIONS: These data demonstrate that YTR107-mediated targeting of NPM1 impairs DNA DSB repair, an event that increases radiation sensitivity.
PURPOSE: To test the hypothesis that small molecule targeting of nucleophosmin 1 (NPM1) represents a rational approach for radiosensitization. METHODS AND MATERIALS: Wilde-type and NPM1-deficient mouse embryo fibroblasts (MEFs) were used to determine whether radiosensitization produced by the small molecule YTR107 was NPM1 dependent. The stress response to ionizing radiation was assessed by quantifying pNPM1, γH2AX, and Rad51 foci, neutral comet tail moment, and colony formation. NPM1 levels in a human-derived non-small-cell lung cancer (NSCLC) tissue microarray (TMA) were determined by immunohistochemistry. YTR107-mediated radiosensitization was assessed in NSCLC cell lines and xenografts. RESULTS: Use of NPM1-null MEFs demonstrated that NPM1 is critical for DNA double- strand break (DSB) repair, that loss of NPM1 increases radiation sensitivity, and that YTR107-mediated radiosensitization is NPM1 dependent. YTR107 was shown to inhibit NPM1 oligomerization and impair formation of pNPM1 irradiation-induced foci that colocalized with γH2AX foci. Analysis of the TMA demonstrated that NPM1 is overexpressed in subsets of NSCLC. YTR107 inhibited DNA DSB repair and radiosensitized NSCLC lines and xenografts. CONCLUSIONS: These data demonstrate that YTR107-mediated targeting of NPM1 impairs DNA DSB repair, an event that increases radiation sensitivity.
Authors: Juliann Chmielecki; Jasmine Foo; Geoffrey R Oxnard; Katherine Hutchinson; Kadoaki Ohashi; Romel Somwar; Lu Wang; Katherine R Amato; Maria Arcila; Martin L Sos; Nicholas D Socci; Agnes Viale; Elisa de Stanchina; Michelle S Ginsberg; Roman K Thomas; Mark G Kris; Akira Inoue; Marc Ladanyi; Vincent A Miller; Franziska Michor; William Pao Journal: Sci Transl Med Date: 2011-07-06 Impact factor: 17.956
Authors: Jonathan D Cheng; Matthildi Valianou; Adrian A Canutescu; Eileen K Jaffe; Hyung-Ok Lee; Hao Wang; Jack H Lai; William W Bachovchin; Louis M Weiner Journal: Mol Cancer Ther Date: 2005-03 Impact factor: 6.261
Authors: Fei Li; Wai-Lung Ng; Troy A Luster; Hai Hu; Vladislav O Sviderskiy; Catríona M Dowling; Kate E R Hollinshead; Paula Zouitine; Hua Zhang; Qingyuan Huang; Michela Ranieri; Wei Wang; Zhaoyuan Fang; Ting Chen; Jiehui Deng; Kai Zhao; Hon-Cheong So; Alireza Khodadadi-Jamayran; Mousheng Xu; Angeliki Karatza; Val Pyon; Shuai Li; Yuanwang Pan; Kristen Labbe; Christina Almonte; John T Poirier; George Miller; Richard Possemato; Jun Qi; Kwok-Kin Wong Journal: Cancer Res Date: 2020-07-09 Impact factor: 12.701
Authors: Narsimha Reddy Penthala; Amit Ketkar; Konjeti R Sekhar; Michael L Freeman; Robert L Eoff; Ramesh Balusu; Peter A Crooks Journal: Bioorg Med Chem Date: 2015-11-15 Impact factor: 3.641
Authors: Joseph K Box; Nicolas Paquet; Mark N Adams; Didier Boucher; Emma Bolderson; Kenneth J O'Byrne; Derek J Richard Journal: BMC Mol Biol Date: 2016-08-24 Impact factor: 2.946